← Eichor
Study identifier: NCT06776523 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Boosting Refugee Integration Through Psychological Intervention

Condition: Psychological Distress · PTSD · Trauma  ·  Sponsor: University of Zurich

PhaseNA
Planned participants1200
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

Refugees and asylum seekers (RAS) face numerous stressors and adversities which put them at risk for developing mental health problems. However, access to adequate mental health care in host countries is limited. To address this problem, the World Health Organization (WHO) introduced Problem Management Plus (PM+), a short, low-intensity psychological intervention administered by non-professionals, aiming to alleviate common mental disorders among crisis-affected communities. The present study aims at expanding the existing PM+ intervention by providing additional booster sessions and homework reminders while evaluating its effectiveness and implementation in the public health system.

This description comes directly from the study's public registry record.

Talk to the study team

Naser Morina, PD Dr.  ·  +41 44 255 5280  ·  naser.morina@usz.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Klinik für Konsiliarpsychiatrie und PsychosomatikZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06776523